We are live on ! Find out more
TI

tru Independence Portfolio holdings

AUM $202M
1-Year Est. Return 15.81%
This Fund
S&P 500
This Quarter Est. Return
+16.99%
1 Year Est. Return
+15.81%
3 Year Est. Return
+42.5%
5 Year Est. Return
+46.34%
10 Year Est. Return
–
AUM
$691K
AUM Growth
+$78K
Cap. Flow
+$226M
Cap. Flow %
32,646.26%
Top 10 Hldgs %
41.04%
Holding
960
New
207
Increased
181
Reduced
170
Closed
53

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$61.5M
2
SCHB icon
Schwab US Broad Market ETF
SCHB
+$54.4M
3
IUSG icon
iShares Core S&P US Growth ETF
IUSG
+$28.9M
4
XOP icon
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
+$16.7M
5
GLD icon
SPDR Gold Trust
GLD
+$9.38M

Top Sells

Rank Stock Value
1
FBT icon
First Trust NYSE Arca Biotechnology Index Fund
FBT
+$10.7M
2
GIS icon
General Mills
GIS
+$5.39M
3
MSFT icon
Microsoft
MSFT
+$3.32M
4
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$3.24M
5
ENR icon
Energizer
ENR
+$2.86M

Sector Composition

Rank Sector Weight
1 Energy 28.66%
2 Technology 9.15%
3 Healthcare 7.9%
4 Financials 6.09%
5 Consumer Discretionary 5.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TDC icon
701
Teradata
TDC
$2.68B
$5 ﹤0.01%
266
– –
TTWO icon
702
Take-Two Interactive
TTWO
$43B
$5 ﹤0.01%
+37
New +$4.84K
WST icon
703
West Pharmaceutical
WST
$23.1B
$5 ﹤0.01%
21
– –
XRX icon
704
Xerox
XRX
$337M
$5 ﹤0.01%
300
– –
SCPX
705
DELISTED
Scorpius Holdings, Inc.
SCPX
– –
0
– –
WORK
706
DELISTED
Slack Technologies, Inc.
WORK
$5 ﹤0.01%
145
+45
+45% +$1.35K
GNMK
707
DELISTED
GenMark Diagnostics, Inc
GNMK
$5 ﹤0.01%
+376
New +$3.82K
AAL icon
708
American Airlines Group
AAL
$9.58B
$4 ﹤0.01%
317
– –
AMCR icon
709
Amcor
AMCR
$20.6B
$4 ﹤0.01%
69
– –
AMTD
710
AMTD IDEA Group
AMTD
$75.7M
$4 ﹤0.01%
83
– –
APA icon
711
APA Corp
APA
$12.8B
$4 ﹤0.01%
300
– –
AVB icon
712
AvalonBay Communities
AVB
$27.1B
$4 ﹤0.01%
23
– –
BBDC icon
713
Barings BDC
BBDC
$862M
$4 ﹤0.01%
500
– –
BIO icon
714
Bio-Rad Laboratories Class A
BIO
$8.42B
$4 ﹤0.01%
+10
New +$4.41K
CAG icon
715
Conagra Brands
CAG
$7.07B
$4 ﹤0.01%
100
– –
CLPR
716
Clipper Realty
CLPR
$46.5M
$4 ﹤0.01%
500
– –
CNP icon
717
CenterPoint Energy
CNP
$29.1B
$4 ﹤0.01%
234
– –
CRON
718
Cronos Group
CRON
$1.05B
$4 ﹤0.01%
675
+400
+145% +$2.44K
DOC icon
719
Healthpeak Properties
DOC
$15.4B
$4 ﹤0.01%
155
+3
+2% +$77
ECON icon
720
Columbia Emerging Markets Consumer ETF
ECON
$327M
$4 ﹤0.01%
195
– –
EMB icon
721
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
$4 ﹤0.01%
+40
New +$4.14K
EQH.PRA icon
722
Equitable Holdings Series A Preferred Stock
EQH.PRA
$620M
$4 ﹤0.01%
200
– –
EQX icon
723
Equinox Gold
EQX
$7.32B
$4 ﹤0.01%
400
– –
EXPO icon
724
Exponent
EXPO
$2.98B
$4 ﹤0.01%
46
– –
EXR icon
725
Extra Space Storage
EXR
$31.2B
$4 ﹤0.01%
40
– –
27 28
29
30 31

Similar funds

4FG
4Thought Financial Group Syosset, New York $202M AUM 11.53% 1-Year Est. Return
BFA
Brendel Financial Advisors Hanover, New Hampshire $202M AUM 37.99% 1-Year Est. Return
PCMK
Paragon Capital Management (Kansas) Overland Park, Kansas $202M AUM 26.44% 1-Year Est. Return
CWM
CarsonAllaria Wealth Management Glen Carbon, Illinois $202M AUM 15.75% 1-Year Est. Return
AFWM
Arta Finance Wealth Management Mountain View, California $202M AUM
HWMO
Heritage Wealth Management (Ohio) Cincinnati, Ohio $202M AUM 23.85% 1-Year Est. Return
PCM
Pointe Capital Management Grosse Pointe Farms, Michigan $202M AUM 17.2% 1-Year Est. Return
BSA
Bull Street Advisors Savannah, Georgia $202M AUM 11.06% 1-Year Est. Return

tru Independence's Q2 2020 Portfolio in Review

As of Q2 2020, tru Independence held 960 positions worth $691K, up 13% from $613K the previous quarter. Its ten largest holdings account for 41% of the portfolio.

tru Independence deployed $226M of net new capital in Q2 2020, opening 207 new positions and adding to 181 existing holdings. Its largest new stake was Bristol-Myers Squibb: 1,027,572 shares worth $19.

By sector, the portfolio is most concentrated in Energy at 29% of assets, up from 2.7% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was First Trust NYSE Arca Biotechnology Index Fund, an estimated $10.7M trimmed.

  • tru Independence's largest Q2 2020 buy was Bristol-Myers Squibb: 1,027,572 shares worth $19.
  • tru Independence added most to SPDR Gold Trust in Q2 2020, an estimated $9.38M increase.
  • tru Independence's biggest Q2 2020 reduction was First Trust NYSE Arca Biotechnology Index Fund, cutting an estimated $10.7M.
  • tru Independence fully exited Bristol-Myers Squibb Company Contingent Value Rights in Q2 2020, selling an estimated $49.3K.
  • tru Independence's ten largest holdings make up 41% of its $691K portfolio in Q2 2020.
  • tru Independence opened 207 new positions and closed 53 in Q2 2020.
  • tru Independence's portfolio value rose 13% quarter-over-quarter to $691K.

Based on tru Independence's 13F filing for Q2 2020, filed 19 Aug 2020.